Noma disease, commonly referred to as cancrum oris, is a fatal and little-known tropical disease that mostly affects malnourished or immunosuppressed children, especially those aged 2-7 years. Noma affects 140,000 children worldwide on an annual basis 1 and is generally prevalent in impoverished or underprivileged areas of developing nations, primarily in Sub-Saharan Africa and some cases in Asia. 2 Known colloquially as "the face of poverty," Noma is a lifethreatening infection that begins as a simple gingival ulceration but quickly spreads, causing extensive damage of the soft and hard tissues of the face leading to permanent facial disfigurement and deformity. WHO estimates that there are presently 770,000 Noma survivors across the world 1 and most of them struggle with a variety of chronic health conditions, including trismus (temporomandibular spasm), trouble speaking, halitosis, oral incontinence, tooth loss, and feeding difficulties. 3,4 These concerns, which arise because of the facial deformities induced by Noma, make it a significant public health concern, impacting the quality of life and functional capacities of affected individuals. 3 While the physical effects are catastrophic, the hidden agony caused by Noma's psychological and social impact is equally severe and demands immediate attention.